KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Return on Sales (2016 - 2025)

Teladoc Health (TDOC) has disclosed Return on Sales for 12 consecutive years, with 0.04% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 4.0% to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.08% through Dec 2025, up 31.0% year-over-year, with the annual reading at 0.08% for FY2025, 31.0% up from the prior year.
  • Return on Sales hit 0.04% in Q4 2025 for Teladoc Health, up from 0.08% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.02% in Q4 2021 to a low of 11.81% in Q1 2022.
  • Historically, Return on Sales has averaged 1.31% across 5 years, with a median of 0.12% in 2023.
  • Biggest five-year swings in Return on Sales: plummeted -1137bps in 2022 and later skyrocketed 1170bps in 2023.
  • Year by year, Return on Sales stood at 0.02% in 2021, then crashed by -30044bps to 5.97% in 2022, then surged by 99bps to 0.04% in 2023, then crashed by -73bps to 0.08% in 2024, then soared by 48bps to 0.04% in 2025.
  • Business Quant data shows Return on Sales for TDOC at 0.04% in Q4 2025, 0.08% in Q3 2025, and 0.05% in Q2 2025.